Your Notifications
All done, no notifications

About Dr. Sezer Saglam

  • Dr. Sezer Sağlam has forged an illustrious career path in internal medicine and oncology, marked by extensive training and significant professional achievements.
  • His journey began in 1991 with medical training at Ege University, followed by completing his Internal Medicine specialty at Cerrahpaşa Medical Faculty in 1996.
  • In 1999, Dr. Sağlam expanded his expertise through a pivotal role at the American Cancer Center of Florence Nightingale Metropolitan Hospital, where he gained valuable experience in oncological care.
  • His commitment to advancing in the field led him to achieve specialization in Medical Oncology at Istanbul University Oncology Institute in 2005, solidifying his credentials in cancer management and treatment.
  • Dr. Sağlam has demonstrated unwavering dedication to patient care and medical advancement throughout his career, evident in his diverse educational background and substantial contributions to internal medicine and oncology.

Conditions treated by Dr. Sezer Sağlam

  • Breast Cancer and Gynecological Cancer
  • Melanoma, Brain Cancer
  • Soft tissue and Bone sarcomas
  • Hematological Malignancies such as lymphomas, leukemias, multiple myelomas
  • Gastrointestinal Cancer
  • Ewing Sarcoma

Area of Interest

  • Medical Oncology
  • Gastrointestinal Cancers
  • Gastric cancer
  • Ewing Sarcoma
  • Internal medicine

Qualification

  • 2005- Istanbul University Oncology Institute
    Medical Oncology Specialization Training
  • 1999- American Cancer Center of Florence Nightingale Metropolitan Hospital
  • 1997-1998: Bayraktar Dialysis Center
  • 1996- Cerrahpaşa Medical Faculty
    Internal Medicine Specialization Training
  • 1991- Ege University
    Medical Training
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

MEMBERSHIPS (3)

  • Medical Oncology Association
  • European Neuroendocrine Tumor Society (ENETS)
  • American Society of Clinical Oncology (ASCO)

RESEARCH PAPERS AND PUBLICATIONS (10)

  • Topuz E, Eralp Y, Saglam S, Saip P, Aydiner A, Berkman S, Yavuz E. Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer. Consolidative intraperitoneal cisplatin in ovarian cancer.Gynecol Oncol. 92(1): 147–5, 2004.
  • Balci NC, Akun E, Erturk M, Saglam S, Inan N, Balci Y. Renal-related perinephric fluid collections: MRI findings. Magn Resonance Imaging. 23(5): 679–84, 2005.
  • Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H. A phase II study of cisplatin, ifosfamide, and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Oncology. 72(3–4): 255–60, 2007.
  • Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu MA, Saglam S, Guney N, Tenekeci AN, Aykan NF. XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer. Oncology. 73(5–6): 298–304, 2007.
  • Topuz E, Derin D, Can G, Kürklü E, Cinar S, Aykan F, Cevikbaş A, Dışçi R, Durna Z, Sakar B, Saglam S, Tanyeri H, Deniz G, Gürer U, Taş F, Güney N, Aydiner A. Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Invest New Drugs. 26(6): 567–72, 2008.
  • Balci NC, Befeler AS, Bieneman BK, Fattahi R, Saglam S, Havlioglu N. Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging. Acad Radiol. 16(8): 963–8, 2009.
  • Balci NC, Perman WH, Saglam S, Akisik F, Fattahi R, Bilgin M. Diffusion-weighted magnetic resonance imaging of the pancreas. Top Magn Reson Imaging. 20(1): 43–7, 2009.
  • Saglam S, Suzme R, Gurdol F. Serum tumor necrosis factor-alpha and interleukin-2 concentrations in newly diagnosed ERBB2 (HER2/neu) positive breast cancer patients. Int J Biol Markers. 24(3): 142–6, 2009.
  • Saglam S, Aykan NF, Şakar B, et al. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma. Journal of Gastrointestinal Oncology.2; 219-26, 2011. Prof. Sezer Saglam, M.D.
  • Effects of surgical laparoscopic experience on the short-term postoperative outcome of rectal cancer: results of a high volume single center institution.Balik E, Asoglu O, Saglam S, Yamaner S, Akyuz A, Buyukuncu Y, Gulluoglu M, Bulut T , Bugra D. Surg Laparosc Endosc Percutan Tech. 2010;20:93-9.

Share Your Experience about Dr. Sezer Saglam

PROCEDURES

  • Adrenal Cancer Treatment
  • Intensity-modulated radiotherapy (IMRT)
  • Malignant Mesothelioma Treatment
  • Nasopharyngeal Cancer Treatment
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Small Intestine Cancer Treatment
  • Thymectomy

FREQUENTLY ASKED QUESTIONS

Q: Is Doctor Sezer Saglam doing teleconsultation on the MediGence platform?

A. Dr. Sezer Saglam is available to teleconsultate on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may go beyond the estimated time which is dependent on the patient’s queries and the medical suggestions of the doctor.

Q: How soon can the consultation be organized?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organized within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided to you on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Is it possible to get the estimate for the procedure?

A. Yes. The cost estimate will be provided to you by our case manager including the doctor’s opinion, the cost estimate, and the crucial information about traveling to your medical destination.

Reviewer

Dr. Vishwas Kaushik
Dr. Vishwas Kaushik

MBBS, MD

7 Years of Experience

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication. View More

Last Reviewed - January 2026

Author

Dr. Shagufta Parveen
Dr. Shagufta Parveen

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

. View More